Barbara Gulanski

2.7k total citations
43 papers, 1.9k citations indexed

About

Barbara Gulanski is a scholar working on Endocrinology, Diabetes and Metabolism, Psychiatry and Mental health and Physiology. According to data from OpenAlex, Barbara Gulanski has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Psychiatry and Mental health and 8 papers in Physiology. Recurrent topics in Barbara Gulanski's work include Diabetes Management and Research (7 papers), Dementia and Cognitive Impairment Research (5 papers) and Bone health and osteoporosis research (5 papers). Barbara Gulanski is often cited by papers focused on Diabetes Management and Research (7 papers), Dementia and Cognitive Impairment Research (5 papers) and Bone health and osteoporosis research (5 papers). Barbara Gulanski collaborates with scholars based in United States, Hong Kong and Brazil. Barbara Gulanski's co-authors include Florian Bieber, Pamela Cyrus, John Orazem, Bianca B. Ruzicka, Liana Fraenkel, John C. Morris, Elizabeth Barrett‐Connor, Gail A. Laughlin, Dick R. Wittink and P. Cyrus and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Barbara Gulanski

41 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Barbara Gulanski United States	22	456	410	383	270	266	43	1.9k
Michael Bodmer Switzerland	33	419 0.9×	549 1.3×	484 1.3×	145 0.5×	899 3.4×	77	4.4k
James G. Flood United States	27	783 1.7×	260 0.6×	281 0.7×	115 0.4×	96 0.4×	73	2.5k
Adam M. Kaye United States	25	596 1.3×	246 0.6×	439 1.1×	92 0.3×	120 0.5×	140	2.9k
Michael Shannon United States	25	770 1.7×	239 0.6×	732 1.9×	606 2.2×	155 0.6×	70	3.0k
Joëlle Micallef France	34	592 1.3×	261 0.6×	898 2.3×	190 0.7×	105 0.4×	226	4.0k
Ismo Räihä Finland	31	690 1.5×	603 1.5×	137 0.4×	45 0.2×	305 1.1×	89	3.5k
Stan Shapiro Canada	25	345 0.8×	261 0.6×	354 0.9×	122 0.5×	389 1.5×	40	2.7k
Shelia Jin United States	16	1.3k 2.8×	1.5k 3.6×	907 2.4×	50 0.2×	480 1.8×	28	3.9k
Peter Manu United States	29	2.2k 4.9×	425 1.0×	314 0.8×	42 0.2×	556 2.1×	108	3.2k
Stephen Wright United Kingdom	30	991 2.2×	226 0.6×	2.7k 6.9×	83 0.3×	290 1.1×	67	4.5k

Countries citing papers authored by Barbara Gulanski

Since Specialization

Citations

This map shows the geographic impact of Barbara Gulanski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Gulanski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Gulanski more than expected).

Fields of papers citing papers by Barbara Gulanski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Gulanski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Gulanski. The network helps show where Barbara Gulanski may publish in the future.

Co-authorship network of co-authors of Barbara Gulanski

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Gulanski. A scholar is included among the top collaborators of Barbara Gulanski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Gulanski. Barbara Gulanski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lipska, Kasia J., Carol Oladele, Barbara Gulanski, et al.. (2024). Association of Race and Ethnicity with Prescriptions for Continuous Glucose Monitoring Systems Among a National Sample of Veterans with Diabetes on Insulin Therapy. Diabetes Technology & Therapeutics. 26(12). 908–917. 2 indexed citations

Lee, Kyung Min, Daniel Becker, Stacy Loeb, et al.. (2022). A Population-Level Analysis of the Protective Effects of Androgen Deprivation Therapy Against COVID-19 Disease Incidence and Severity. Frontiers in Medicine. 9. 774773–774773. 9 indexed citations

Ash, Garrett I., Stephanie Griggs, Laura M. Nally, et al.. (2021). Evaluation of Web-Based and In-Person Methods to Recruit Adults With Type 1 Diabetes for a Mobile Exercise Intervention: Prospective Observational Study. JMIR Diabetes. 6(3). e28309–e28309. 9 indexed citations

Kohler, Minna J., et al.. (2013). Use of a Computerized Order Set to Increase Prescription of Calcium and Vitamin D Supplementation in Patients Receiving Glucocorticoids. Journal of General Internal Medicine. 28(6). 825–829. 10 indexed citations

Womack, Julie A., Joseph L. Goulet, Cynthia L. Gibert, et al.. (2011). Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans. PLoS ONE. 6(2). e17217–e17217. 211 indexed citations

Yeckel, Catherine W., et al.. (2009). Simple Exercise Recovery Index for Sympathetic Overactivity Is Linked to Insulin Resistance. Medicine & Science in Sports & Exercise. 41(3). 505–515. 8 indexed citations

Fraenkel, Liana, Barbara Gulanski, & Dick R. Wittink. (2006). Patient treatment preferences for osteoporosis. Arthritis Care & Research. 55(5). 729–735. 59 indexed citations

Fraenkel, Liana, Barbara Gulanski, & Dick R. Wittink. (2006). Patient willingness to take teriparatide. Patient Education and Counseling. 65(2). 237–244. 21 indexed citations

Bravata, Dawn M., Carolyn K. Wells, Walter N. Kernan, et al.. (2005). Association between Impaired Insulin Sensitivity and Stroke. Neuroepidemiology. 25(2). 69–74. 21 indexed citations

10.

Bravata, Dawn M., Carolyn K. Wells, John Concato, et al.. (2004). Two measures of insulin sensitivity provided similar information in a U.S. population. Journal of Clinical Epidemiology. 57(11). 1214–1217. 33 indexed citations

11.

Sernyak, Michael J., Barbara Gulanski, Douglas Leslie, & Robert A. Rosenheck. (2003). Undiagnosed Hyperglycemia in Clozapine-Treated Patients With Schizophrenia. The Journal of Clinical Psychiatry. 64(5). 605–608. 31 indexed citations

12.

Barrett‐Connor, Elizabeth, et al.. (2003). Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial. The Journal of Clinical Endocrinology & Metabolism. 88(4). 1646–1652. 122 indexed citations

13.

Masiukiewicz, Urszula, Maryann Mitnick, Barbara Gulanski, & Karl Insogna. (2002). Evidence that the IL-6/IL-6 Soluble Receptor Cytokine System Plays a Role in the Increased Skeletal Sensitivity to PTH in Estrogen-Deficient Women. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2892–2898. 20 indexed citations

14.

Blass, John P., Pamela Cyrus, Florian Bieber, & Barbara Gulanski. (2000). Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Tolerability of Metrifonate in Patients with Probable Alzheimer Disease. Alzheimer Disease & Associated Disorders. 14(1). 39–45. 21 indexed citations

15.

Raskind, Murray A., et al.. (1999). The Effects of Metrifonate on the Cognitive, Behavioral, and Functional Performance of Alzheimer's Disease Patients. The Journal of Clinical Psychiatry. 60(5). 318–325. 82 indexed citations

16.

Jann, Michael W., et al.. (1999). Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double-masked, placebo-controlled trial. Clinical Therapeutics. 21(1). 88–102. 12 indexed citations

17.

Cyrus, P., et al.. (1999). Metrifonate treatment of AD. Neurology. 53(9). 2010–2010. 46 indexed citations

18.

Cutler, Neal R., Stanford S. Jhee, Pamela Cyrus, et al.. (1998). Safety and tolerability of metrifonate in patients with alzheimer's disease: Results of a maximum tolerated dose study. Life Sciences. 62(16). 1433–1441. 15 indexed citations

19.

Seeman, Teresa E., Lisa Berkman, Barbara Gulanski, et al.. (1995). Self-esteem and neuroendocrine response to challenge: MacArthur studies of successful aging. Journal of Psychosomatic Research. 39(1). 69–84. 80 indexed citations

20.

Brines, Michael, et al.. (1991). Cytoarchitectural relationships between [3H]ouabain binding and mRNA for isoforms of the sodium pump catalytic subunit in rat brain. Molecular Brain Research. 10(2). 139–150. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact